跳至主導覽 跳至搜尋 跳過主要內容

Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment

  • Tianhe Li
  • , Sepehr Akhtarkhavari
  • , Sumeng Qi
  • , Jiawei Fan
  • , Tu Yung Chang
  • , Yao An Shen
  • , Jin Ming Yang
  • , Barbara S. Slusher
  • , Ie Ming Shih*
  • , Stephanie Gaillard*
  • , Tian Li Wang*
  • *此作品的通信作者
  • Johns Hopkins University
  • Taipei Medical University
  • University of Kentucky Markey Cancer Center

研究成果: 期刊稿件 › 文章 › 同儕審查

7 引文 斯高帕斯(Scopus)

摘要

Targeting glutamine metabolism has emerged as a promising strategy in cancer therapy. To attain clinical utility, a number of challenges must be overcome, including in vivo anti-tumor activity, pharmacological toxicity, and clinical safety. Aside from glutamine-addicted tumor cells, immune cells may also need glutamine to sustain physiological activities; thus, the current work used two immunological-intact murine cancer models to assess the effects of glutamine antagonists on tumor cells and the immune milieu. To minimize potential off-target effects, we developed a glutamine antagonist prodrug, JHU083, which is bioactivated selectively in cancer tissues. In both murine tumor models, we observed a significant anti-tumor effect, resulting in reduced tumor burden and impeded tumor progression. Single-cell RNA sequencing of tumor tissues demonstrated that JHU083 significantly hampered the immunosuppressive M2-like macrophages but not the pro-inflammatory M1-like macrophages. Expression of Myc- and hypoxia-regulated genes were also inhibited by JHU083. Ex vivo bone marrow-derived macrophage cultures further confirmed that M2 macrophages were more sensitive to glutamine antagonist than M1 macrophages. Together, our findings indicate that JHU083 exerted its anti-tumor activity not only through direct targeting of glutamine-addicted cancer cells but also by shifting the M1/M2 macrophage landscape in favor of an immune-stimulatory microenvironment.

原文英語
文章編號e00738
頁(從 - 到)e00738
期刊Advanced Biology
卷9
發行號10
DOIs
出版品狀態已出版 - 10 2025

文獻附註

Publisher Copyright:
© 2025 The Author(s). Advanced Biology published by Wiley-VCH GmbH.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment」主題。共同形成了獨特的指紋。

引用此